PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

por Smeltzer, M., Bunn, P.A., Clark, R., Arndt, R., Pruett, C., Roy, U., Hirsch, F., Mitsudomi, T., Wakelee, H., Scagliotti, G.
Publicado 2021

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

por Hirsch, F R, Varella-Garcia, M, Franklin, W A, Veve, R, Chen, L, Helfrich, B, Zeng, C, Baron, A, Bunn, P A
Publicado 2002

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

por Cappuzzo, F, Toschi, L, Domenichini, I, Bartolini, S, Ceresoli, G L, Rossi, E, Ludovini, V, Cancellieri, A, Magrini, E, Bemis, L, Franklin, W A, Crino, L, Bunn, P A, Hirsch, F R, Varella-Garcia, M
Publicado 2005

OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls

por Gomez, J., Krammer, F., Mack, P., Rolfo, C., Rohs, N., Moore, A., King, J., Henschke, C., Yankelevitz, D., Shyr, Y., Taioli, E., Fontoura, B., Brody, R., Gerber, D., Minna, J., Bunn, P.A., Garcia-Sastre, A., Hirsch, F.
Publicado 2021

OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study

por Mack, P.C., Gomez, J.C., Rodilla, A., Carreño, J.M., Hsu, C.-Y., Rolfo, C.D., Meshulami, N., Moore, A., Brody, R., King, J.C., Treatman, J., Lee, S., Raskin, A., Srivastava, K., Gleason, C.R., Tcheou, J., Bielak, D., Acharya, R., Gerber, D.E., Rohs, N., Henschke, C.I., Yankelevitz, D.F., Simon, V., Minna, J.D., Bunn, P.A., García- Sastre, A., Krammer, F., Shyr, Y., Hirsch, F.R.
Publicado 2022